新闻
2024-03-01
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission
临床3期申请上市
2024-03-01
Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome
临床研究孤儿药快速通道基因疗法
2024-03-01
Viracta Therapeutics Announces Completion of Second-Stage Enrollment into the Peripheral T-Cell Lymphoma Cohort of the NAVAL-1 Trial
细胞疗法
2024-03-01
引进/卖出抗体药物偶联物
2024-03-01
Clene Presents Clinical Results of CNM-Au8® 30mg Treatment From Visionary-MS Trial Long-Term Extension at Annual ACTRIMS Forum 2024
临床结果
2024-03-01
快速通道基因疗法
2024-02-29
Gain Therapeutics Announces the Initiation of the Multiple Ascending Dose (MAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
临床研究
2024-02-29
BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
临床2期
2024-02-29
带量采购
2024-02-29
TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)
上市批准临床结果疫苗